-
1
-
-
0019251726
-
Growth characteristics and ultra-structure of human retinal pigment epithelium in vitro
-
Flood M T, Gouras P, Kjeldbye H. Growth characteristics and ultra-structure of human retinal pigment epithelium in vitro. Invest Ophthalmol Vis Sci, 1980,19:1309-1320
-
(1980)
Invest Ophthalmol Vis Sci
, vol.19
, pp. 1309-1320
-
-
Flood, M.T.1
Gouras, P.2
Kjeldbye, H.3
-
2
-
-
0029019576
-
Genetic engineering of vein grafts resistant to atherosclerosis
-
10
-
Mann M J, Gibbons G H, Kernoff R S et al. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci USA, 1995,92(10): 4502-4506
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 4502-4506
-
-
Mann, M.J.1
Gibbons, G.H.2
Kernoff, R.S.3
-
3
-
-
0024093159
-
The cytoskeletal element of human retinal pigment epitherlium: In vitro and in vivo
-
Mckechnie N M, Boulton M, Robey H L et al. The cytoskeletal element of human retinal pigment epitherlium: in vitro and in vivo. J Cell Sci, 1988, 91:303-312
-
(1988)
J Cell Sci
, vol.91
, pp. 303-312
-
-
McKechnie, N.M.1
Boulton, M.2
Robey, H.L.3
-
4
-
-
0023447252
-
Lipofectin: A hightly efficient, lipid-mediated DNA-transfection procedure
-
Felgner P L, Gadek T R, Holm M et al. Lipofectin: a hightly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA, 1987,84:7413-7417
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 7413-7417
-
-
Felgner, P.L.1
Gadek, T.R.2
Holm, M.3
-
6
-
-
0024311413
-
Proliferative vitreoretinopathy membrances. An immunohistochemical study
-
Jerdan, J A, Pepose J S, Miechel RG et al. Proliferative vitreoretinopathy membrances. An immunohistochemical study. Ophtholmol, 1989,96: 801-810
-
(1989)
Ophtholmol
, vol.96
, pp. 801-810
-
-
Jerdan, J.A.1
Pepose, J.S.2
Miechel, R.G.3
-
7
-
-
0024554274
-
Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle
-
7
-
Liu Y C, Marraccino R L, Keng P C et al. Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle. Biochemistry, 1989,28(7):2967-2974
-
(1989)
Biochemistry
, vol.28
, pp. 2967-2974
-
-
Liu, Y.C.1
Marraccino, R.L.2
Keng, P.C.3
-
8
-
-
0024283320
-
Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin
-
4858
-
Jaskulski D, deRiel J K, Mercer W E et al. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science, 1988,240(4858):1544-1546
-
(1988)
Science
, vol.240
, pp. 1544-1546
-
-
Jaskulski, D.1
Deriel, J.K.2
Mercer, W.E.3
-
9
-
-
0025131814
-
Antisense strategies in cell and developmental biology
-
Colman A. Antisense strategies in cell and developmental biology. J Cell Sci, 1990,97:399-409
-
(1990)
J Cell Sci
, vol.97
, pp. 399-409
-
-
Colman, A.1
-
10
-
-
0023921083
-
Oligodeoxynucleotides as inhibitors of gene express: A review
-
Stein C, Cohen J. Oligodeoxynucleotides as inhibitors of gene express: A review. Cancer Res, 1988,48:2659-2688
-
(1988)
Cancer Res
, vol.48
, pp. 2659-2688
-
-
Stein, C.1
Cohen, J.2
-
11
-
-
0001294841
-
The role of smooth muscle cell in fibrogenesis of arterosclerosis
-
Haust D A, More R H, Movat H Z. The role of smooth muscle cell in fibrogenesis of arterosclerosis. Am J Pathol, 1960,37: 377-388
-
(1960)
Am J Pathol
, vol.37
, pp. 377-388
-
-
Haust, D.A.1
More, R.H.2
Movat, H.Z.3
-
12
-
-
0027323303
-
Single intraluminal delivery of antisense cdc2kinase and proliferating-cell nuclear antigen oligonucleotides results in chroric inhibition of neointimal hyperplasia
-
10
-
Morishita R, Gibbons G H, Ellison K E et al. Single intraluminal delivery of antisense cdc2kinase and proliferating-cell nuclear antigen oligonucleotides results in chroric inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA, 1993,90(10):8474-8478
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 8474-8478
-
-
Morishita, R.1
Gibbons, G.H.2
Ellison, K.E.3
-
13
-
-
0030893643
-
Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts
-
6
-
Mann M J, Gibbons G H, Tsao P S et al. Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts. J Clin Invest, 1997, 99(6): 1295-1301
-
(1997)
J Clin Invest
, vol.99
, pp. 1295-1301
-
-
Mann, M.J.1
Gibbons, G.H.2
Tsao, P.S.3
|